Indications Dosages Interactions Precautions Contraindications Adverse Reactions

Precautions:  Monitor LFT (Serum transaminases) before therapy, every 6 weeks in the 1st 3 months of therapy then every 8 weeks in the 1st year & periodically thereafter. Hepatic disease, Myopathy/ARF (secondary to Rhabdomyolysis) prone conditions, eg Major Surgery, Trauma, Seizures, Metabolic/Endocrine/Electrolyte disorder, Myalgia or Weakness, esp. with Fever or Malaise.

Salmeterol Xinafoate Silver Nitrate Sodium Bicarbonate Sodium Fluoride Sodium Phosphates Somatropin Spironolactone Stavudine Streptomycin Sulfate Sulfacetamide Sodium Sulfasalazine Sulfisoxazole Saccharine Saccharomyces Salbutamole Salbutamole - inh Salicylates Salmeterol - inh Satranidazole Sacnidazole Selegiline Senna Serratiopeptidase Sertraline Sibutramine Sildenafil citrate Silver Sulfadiazine - Ocular Silver Sulphadiazine Silymarin Simvastatin Sisomicin Sisomicin - Ocular Snake Venom Antisera Sod Picosulphate Sodium Antimony Gluconate Sodium Cromoglycate Sodium Cromoglycate - Inh Sodium Cromoglycate - Ocular Sodium Fusidate Sodium Hyaluronate Sodium Nitroprusside Sodium Valproate Sodium tetradecyl Soframycin - Ocular Somatostatin Sotalol Sparfloxacin Spectinomycin Spiramycin Stanozolol Streptokinase Streptomycin Succinyl Choline Sucralfate Sulbutiamine Sulfonamide - VU Sulphacetamide - Ocular Sulphadiazine Sulphamethizole Sulphasalazine-Antisecr Sumatriptan